Key result
Omega-3 supplementation improves cardiometabolic markers, blood pressure, and inflammation in metabolic syndrome.
RCT (n=120)
Open-label
Randomly allocated
Answers are grounded in this paper and cite their sources.
OBJECTIVE: Fish-oil contains high concentrations of omega-3 fatty acids that have been shown to have anti-inflammatory properties. We have evaluated the effects of purified omega-3 fatty acid supplements on several anthropometric and biochemical parameters, including heat shock protein (Hsp) 27 antibody titres in subjects with metabolic syndrome. METHODS: Subjects (n = 120) with metabolic syndrome (mean age of 52.9 +/- 11.9 years) were randomly allocated to one of two groups: sixty subjects were given 1 gram of fish oil as a single capsule, containing 180 mg eicosapentaenoic acid and 120 mg docosahexaenoic acid daily for 6 months. Control subjects did not receive any supplementation over the same period. RESULTS: The study was completed by 47 subjects in the intervention group and 42 subjects in the control group. Treatment with omega 3 supplements was associated with a significant fall in body weight (P < 0.05), systolic blood pressures (P < 0.05), serum low density lipoprotein cholesterol (P < 0.05), and total cholesterol (P < 0.05), triglycerides (P < 0.05), high-sensitivity C-reactive protein (hs-CRP) (P < 0.01), and Hsp27 antibody titres (P < 0.05). No significant changes were observed in the control group. CONCLUSION: It appears that omega 3 improves the cardiovascular risk profile of subjects with metabolic syndrome, having effects on weight, systolic blood pressure, lipid profile and markers of inflammation and autoimmunity.
No takes yet. Share an insight, caveat, or question.
Ebrahimi et al. (2009) conducted an RCT in Metabolic syndrome (n=120). Purified omega-3 fatty acid supplement (fish oil) vs. No supplementation was evaluated on Anthropometric and biochemical parameters including body weight, systolic blood pressure, lipid profile, hs-CRP, and Hsp27 antibody titres (p=<0.05). Omega-3 supplementation (1 g/day) reduced weight, systolic BP, LDL-C, triglycerides, hs-CRP, and Hsp27 antibody titres in metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: